Lieske H. Schrijver

Do BRCA1/2 mutation carriers have an earlier onset of natural menopause?

M. Adank, S. Verhoef, C. V. van Asperen, 2016, Menopause.

Use of Exogenous Hormones and Risks of Breast and Ovarian Cancers in BRCA1/2 Mutation Carriers; Methodological and Clinical Considerations

M. Rookus, Lieske H. Schrijver, Susanne Jansen, 2014, Current Breast Cancer Reports.

Oral Contraceptive Use and Breast Cancer Risk: Retrospective and Prospective Analyses From a BRCA1 and BRCA2 Mutation Carrier Cohort Study

W. Chung, R. Eeles, J. Hopper, 2018, JNCI cancer spectrum.

Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers

C. V. van Asperen, J. Oosterwijk, C. J. Asperen, 2018, British Journal of Cancer.

Epidemiology Ovarian stimulation for IVF and risk of primary breast cancer in BRCA 1 / 2 mutation carriers

J. Oosterwijk, C. J. Asperen, M. Ausems, 2018 .

Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study

R. Eeles, J. Hopper, D. Easton, 2021, American journal of obstetrics and gynecology.

Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers: Absolute Cancer Risks and Benefits

E. John, D. Easton, A. Antoniou, 2022, Journal of the National Cancer Institute.

Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers

C. V. van Asperen, J. Oosterwijk, F. V. van Leeuwen, 2018, British Journal of Cancer.

Dietary vitamin A intake below the recommended daily intake during pregnancy and the risk of congenital diaphragmatic hernia in the offspring.

D. Tibboel, R. Steegers-Theunissen, J. Lindemans, 2013, Birth defects research. Part A, Clinical and molecular teratology.

Abstract 4276: Oral contraceptive use and breast cancer risk: a cohort study ofBRCA1andBRCA2mutation carriers

J. Hopper, D. Easton, A. Antoniou, 2017 .